Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
Clinical trial NCT00014664 · UNKNOWN
Trial details
- NCT number
- NCT00014664
- Sponsor
- PDL BioPharma, Inc.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2000-10-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.